MediPal Holdings Corporation carries a market capitalization of 3.76B, placing it among publicly traded companies globally. Its enterprise value stands at 286.88B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.76B |
| Enterprise Value | 286.88B |
MediPal Holdings Corporation currently has 207.95M shares outstanding.
| Shares Outstanding | 207.95M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
MediPal Holdings Corporation trades at a trailing price-to-earnings ratio of 16.41. The price-to-sales ratio is 0.22, and the price-to-book ratio stands at 0.84.
| PE Ratio | 16.41 |
| PS Ratio | 0.22 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, MediPal Holdings Corporation trades at an EV/EBITDA multiple of 10.74 and an EV/FCF ratio of 102,796.25. The EV/Sales ratio of 0.16 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.74 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.16 |
| EV / EBITDA | 10.74 |
| EV / EBIT | 10.74 |
| EV / FCF | 102,796.25 |
MediPal Holdings Corporation maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.23 |
| Quick Ratio | 0.24 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 6,675.00 |
MediPal Holdings Corporation posts a return on equity of 5.27 and a return on invested capital of 2.47.
| Return on Equity (ROE) | 5.27 |
| Return on Assets (ROA) | 1.32 |
| Return on Invested Capital (ROIC) | 2.47 |
| Return on Capital Employed (ROCE) | 3.25 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 8.84 |
Over the trailing twelve months, MediPal Holdings Corporation has paid 12.67B in income taxes, reflecting an effective tax rate of 30.23.
| Income Tax | 12.67B |
| Effective Tax Rate | 30.23 |
MediPal Holdings Corporation's stock has gained approximately 4.43939% over the past 52 weeks. The 50-day moving average sits at 18.74, while the 200-day moving average is 17.49.
| Beta (5Y) | N/A |
| 52-Week Price Change | 4.43939% |
| 50-Day Moving Average | 18.74 |
| 200-Day Moving Average | 17.49 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, MediPal Holdings Corporation generated 1.78T in revenue and converted that into 24.32B in net income, yielding earnings per share of 139.42. EBITDA reached 26.70B, while operating income came in at 26.70B.
| Revenue | 1.78T |
| Gross Profit | 125.28B |
| Operating Income | 26.70B |
| Pretax Income | 41.90B |
| Net Income | 24.32B |
| EBITDA | 26.70B |
| EBIT | 26.70B |
| Earnings Per Share (EPS) | 139.42 |
Total book value stands at 473.08B, with working capital of 244.53B providing operational flexibility.
| Cash & Cash Equivalents | 251.39B |
| Total Debt | N/A |
| Net Debt | -251.09B |
| Equity (Book Value) | 473.08B |
| Book Value Per Share | 2,256.14 |
| Working Capital | 244.53B |
MediPal Holdings Corporation operates with a gross margin of 7.04, reflecting its pricing power and cost economics. The operating margin of 1.50 and net profit margin of 1.37 provide insight into operational efficiency.
| Gross Margin | 7.04 |
| Operating Margin | 1.50 |
| Pretax Margin | 2.35 |
| Profit Margin | 1.37 |
| EBITDA Margin | 1.50 |
MediPal Holdings Corporation posts an Altman Z-Score of 1.73, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.73 |